ACH
Accendra Health Inc
0.5052$
-9.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Accendra Health Inc (ACH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -102 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 188 | 8.0 | 33 | 92 | 43 | 1.6 | -14 | 95 | 59 | 135 | -74 | 220 | 63 | 176 | 243 | 68 | 219 | 141 | -3.8 | 270 | 187 | 57 | 116 | 166 | 339 | 124 | 325 | 741 | 161 | -102 | |
| 16 | 18 | 18 | 19 | 22 | 22 | 16 | 16 | 15 | 19 | 29 | 39 | 22 | 25 | 29 | 34 | 40 | 51 | 63 | 66 | 55 | 59 | 102 | 117 | 93 | 91 | 229 | 287 | 265 | 215 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 7.6 | 7.0 | 6.4 | 5.7 | 5.7 | 6.4 | 8.2 | 11 | 12 | 12 | 16 | 16 | 20 | 25 | 21 | 23 | 27 | 13 | |
| 157 | -38 | -42 | 36 | 13 | -73 | -79 | 0.2 | -35 | 40 | -195 | 84 | -108 | -0.3 | 79 | -118 | 59 | -31 | -153 | 93 | 3.2 | -46 | 14 | 61 | 79 | -261 | 90 | 522 | -25 | 65 | |
| 6.2 | 12 | 13 | 105 | 8.0 | 10 | 9.8 | 18 | 18 | 30 | 39 | 31 | 18 | 32 | 41 | 36 | 39 | 60 | 71 | 37 | 30 | 51 | 66 | 52 | 59 | 50 | 167 | 208 | 228 | 201 | |
| -6.4 | -10 | -13 | -107 | -20 | -18 | -9.7 | -17 | -19 | -105 | -210 | -15 | -131 | 42 | -37 | -34 | -191 | -57 | -317 | -36 | -25 | -417 | -816 | -52 | 80 | -54 | -1,804 | -137 | -117 | 144 | |
| 11 | 11 | 9.3 | 7.5 | 8.2 | 9.2 | 11 | 13 | 17 | 21 | 24 | 28 | 33 | 38 | 45 | 51 | 56 | 61 | 63 | 64 | 63 | 63 | 48 | 5.2 | 0.6 | 0.7 | 0.0 | 0.0 | – | – | |
| – | – | -115 | – | – | – | -6.6 | -31 | – | – | – | – | – | – | – | -16 | -15 | -19 | -9.9 | -20 | -71 | -5.0 | – | – | – | – | 0.0 | 0.0 | 0.0 | -10 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -81 | 1,583 | -417 | -244 | 204 | |
| -181 | 1.9 | -20 | 15 | -23 | 16 | 26 | -65 | 0.2 | -14 | 216 | -208 | 65 | -129 | -142 | -58 | -68 | -82 | 279 | -124 | -142 | 273 | 701 | -130 | -379 | -129 | 1,497 | -417 | -268 | 188 | |
| 0.5 | -0.2 | -0.2 | 0.2 | 0.0 | 0.3 | 2.4 | 13 | 39 | 16 | -67 | -3.0 | 5.8 | 88 | 63 | -23 | -38 | 4.0 | -45 | 104 | 24 | -81 | -1.2 | -19 | 50 | -62 | 14 | 187 | -224 | 233 | |
| 182 | -4.0 | 20 | -13 | 35 | -8.5 | -24 | 77 | 40 | 105 | -112 | 189 | 58 | 143 | 202 | 32 | 180 | 80 | -75 | 233 | 157 | 6.0 | 50 | 114 | 280 | 74 | 158 | 533 | -67 | -303 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.